Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions often highlight specific aspects of the findings, such as the note that TAVR and surgical outcomes are statistically similar despite slight differences, as seen in posts mentioning the 'no significant between-group difference' in outcomes. Phrases reflecting concern about the statistical significance of the results, such as 'confidence intervals' and 'non-cardiac deaths,' indicate the careful consideration being given to the implications of the research. Overall, the tone is balanced, mixing acknowledgment of the positive outcomes with a nuanced understanding of the statistical context.
The discussions generally reflect a supportive view of the publication's findings, with participants acknowledging the relevance of the study.
There is a strong interest indicated by the number of people engaging with the topic and sharing details about the study.
While most interactions provide brief comments or shares, some posts feature deeper analyses of specific outcomes, reflecting moderate engagement.
Many contributors believe the study will influence clinical practices, particularly regarding the choice between TAVR and surgery.
Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes. View the full Research Summary: https://t.co/hnej7UHl72
✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7UHSWA #TCT2023 #cardiology https://t.co/oEceWCu6Rw
Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7UHSWA Editorial: The Changing Landscape of Aortic-Valve Stenosis Management https://t.co/4ZgZ14wGfN #Cardiology
This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/qDvAMvDoH3
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM #TCT2023 https://t.co/TWDLpGlOOW
This video analyzes the comparative outcomes of transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) in low-risk patients. The study reveals TAVR's slightly better outcomes at one…
This podcast discusses the four pillars of cardiology today, including the comparison of transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement in low-risk patients. Dr. John Mandrola…
@rajivxgulati Non-cardiologist, non-surgeon here but I saw this recently https://t.co/HjuLRkzpS0
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
"Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry." Publié ce jour dans Circulation. #MedSky #CardioSky www.ahajournals.org/doi/full/10....
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years https://t.co/W4gHqCybVA
@drjohnm In the 5 year outcome data, the HR direction was there but the statistical significance poor. Can’t ignore diverging curves but at least according to trial these are non-cardiac deaths and wide confidence intervals. https://t.co/nf3Z6LCsk0
5/ Next, Dr. Elmariah focuses on interventional
RT @JMMComendador:
RT @JMMComendador:
RT @echo_batman: @ovidiogarciav @echo_stepbystep @ToDoenst @iamritu @MAecocardio @VDelgadoGarcia @dr_benoy_n_shah @ABeneduceMD @JGrapsa @mj…
@ovidiogarciav @echo_stepbystep @ToDoenst @iamritu @MAecocardio @VDelgadoGarcia @dr_benoy_n_shah @ABeneduceMD @JGrapsa @mjschuuring @schaefers_hans @DrMarthaGulati https://t.co/ILxQ5iS0o4
RT @BJSAcademy:
RT @BJSAcademy:
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years #science #publication #research #journal https://t.co/qpHCQ1JyWP
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years #science #publication #research #publications https://t.co/oQqfMJ1Qtq
RT @DFCapodanno: Five year results of PARTNER 3 trial now published in the NEJM. Conclusions are based on the primary composite outcomes, b…
RT @SeeFisch: FIVE YEARS OF TAVR AS THE STANDARD OF CARE AND GOING STRONG Transcatheter Aortic-Valve Replacement in Low-Risk Patients at F…
FIVE YEARS OF TAVR AS THE STANDARD OF CARE AND GOING STRONG Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/1guKc9Rjzy
2 min cardiology（臨床論文、担当：進藤智彦） Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years M.J.Mack, et al. The New England Journal of Medicine 2023；389：1949-60 DOI: 10.1056/NEJMoa2307447 #Cardiology ＃TAVR
RT @bogamisa: أثبتت الدراسات المنشورة حديثا ان زراعة الصمام الأورطي في المرضى الأصغر سنا ٦٥- ٧٠ عاما و بعد متابعة من ٣ - ٥ سنوات الذين ليس…
أثبتت الدراسات المنشورة حديثا ان زراعة الصمام الأورطي في المرضى الأصغر سنا ٦٥- ٧٠ عاما و بعد متابعة من ٣ - ٥ سنوات الذين ليس لديهم عوامل خطورة عالية لإجراء عملية قلب لتغيير الصمام جراحيا نجاعة زراعة الصمام بالقسطرة للمرضى الذين لا يفضلون الإجراء الجراحي https://t.co/duCxJC2I1p
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/0hHI5aceaF 選んだ外科医が悪すぎるんちゃう？
TAVR vs. SAVR in Low-Risk Aortic Stenosis Patients - A Comparative Tune of Cardiac Success https://t.co/D0xN0uXxaV
結局どっちがいいか。 TAVR群でエンドポイント発生率は低く5年間のアウトカムに有意差なし。 https://t.co/geRSJ9wsga 背景：低リスクな重症大動脈弁狭窄症患者でTAVRと手術の効果を比較。 方法：TAVR、手術を受けた1000人の患者、エンドポイントは死亡、脳卒中、再入院 N Engl J Med, 2023
RT @toki_wo_koe: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/a8Vtp1hl1F
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/a8Vtp1hl1F
Al final del día… eran iguales: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/Mog8qaRWb4
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
RT @NEJM: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-…
Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes. View the full Research Summary: https://t.co/hnej7UHl72
Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery outcomes were similar at Five Years | NEJM @alexsfelixecho @pabeda1 @FaustoHerediaDr @EzequielZaidel https://t.co/40qxzS1KTE
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/1pLwMKsRnd 手術リスクの低い重症ASのTAVRとSVARで死亡or脳卒中or再入院で差があるかを調べたRCT 結果は、5年間で差はなかった(22.8vs27.2%;差:-4.3%[-9.9to1.3]) #当麻_循環
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @AugoustidesJohn: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | #TAVR5 https://t.co/pX3nv5QNYB
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
RT @javier20ch: ✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years @NEJM https://t.co/x0NJ1qVxje
✨️PARTNER 3 trial➡️ Reemplazo percutáneo de valvula aórtica (a 5 años).
https://t.co/x0eKkCvcfz
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
Best article in #tavr today: https://t.co/q1MRSXrtMd Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes. @TheDoctorMack @VinodThourani #PCRLV
RT @AAlMohammad87: #PARTNER_3: 5 yr outcome of #TAVR(TAVI) vs #SAVR in symptomatic severe #AS and low risk @NEJM: no significant between-gr…
#PARTNER_3: 5 yr outcome of #TAVR(TAVI) vs #SAVR in symptomatic severe #AS and low risk @NEJM: no significant between-group difference in the two primary composite outcomes #cardioTwitter Longer term outcomes are very important in low risk pts https://t.co/nWHoYd561V
RT @AugoustidesJohn: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | #TAVR5 https://t.co/pX3nv5QNYB
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @AugoustidesJohn: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | #TAVR5 https://t.co/pX3nv5QNYB
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | #TAVR5 https://t.co/pX3nv5QNYB
https://t.co/By6CMX8enP TAVRの予後が一年時点ではSAVRより良いのに三年時点では差がないとな…？
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7UHSWA Editorial: The Changing Landscape of Aortic-Valve Stenosis Management https://t.co/4ZgZ14wGfN #Cardiology
RT @JMMComendador:
RT @JMMComendador:
RT @JMMComendador:
RT @JMMComendador:
RT @JMMComendador:
RT @JMMComendador:
RT @JMMComendador:
Dra. Flávia Bittar, comenta sobre o estudo Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years, um ensaio clínico feito em pacientes com estenose aórtica grave e sintomática e com baixo risco cirúrgico. Acesse
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
RT @ctsnetorg: JANS: “Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years” from The New England Journal of Medicine |…
RT @ctsnetorg: JANS: “Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years” from The New England Journal of Medicine |…
RT @ctsnetorg: JANS: “Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years” from The New England Journal of Medicine |…
JANS: “Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years” from The New England Journal of Medicine | At five years after surgery, there was a significant difference in morbidity between TAVR and SAVR.
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years #science #publication #research #journal https://t.co/3CKghld4DE
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @hahn_rt: Partner 3 equivalent great outcomes at 5 yrs for TAVR and Surgery (low risk). Both with all-cause mortality </= 10%!! Publish…
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. https://t.co/F51q42NDZs
RT @hahn_rt: Partner 3 equivalent great outcomes at 5 yrs for TAVR and Surgery (low risk). Both with all-cause mortality </= 10%!! Publish…
RT @kaulcsmc: Key data from 5-yr f/u of PARTNER 3 HR for death or disabling stroke shifted from 0.32, 0.11-0.89 at 1y to 1.17, 0.78-1.75 a…
RT @kaulcsmc: Can one infer 'similarity' if prespecified superiority hypothesis is not validated? https://t.co/dO8CGCjOFx https://t.co/L5…
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/R7qWS3iFvN
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years (5y PARTNER 3) @ctsnetorg Journal And News Scan #JANS
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/LqRgymAIUP
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
RT @PPibarot: This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aorti…
This is the 5-years analysis of the PARTNER 3 that we presented at TCT and published in NEJM 2 days ago. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/qDvAMvDoH3
RT @VictorDayan1: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM. Great results. Patients with upto 5 yea…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years Among low-risk patients with severe, symptomatic AS who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes https://t.co/APlWlLFi3f
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/IsOLeBlvwL
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @VictorDayan1: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM. Great results. Patients with upto 5 yea…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7U…
Original Article: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3 trial) https://t.co/hnej7UHSWA #TCT2023 #cardiology https://t.co/oEceWCu6Rw
RT @VictorDayan1: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM. Great results. Patients with upto 5 yea…
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years www.nejm.org/doi/full/10....
RT @VijayKunadian: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM #TCT2023 https://t.co/TWDLpGlOOW
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/Y3AHwd9qIz
RT @davidcalle1390: ❤️
RT @VijayKunadian: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM #TCT2023 https://t.co/TWDLpGlOOW
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/OyrpnZGM5B
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/5VmkdW0JE9
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM. Great results. Patients with upto 5 years life expectancy may be treated with either SAVR or TAVR safely. https://t.co/jwwZdclE4B
#tavi #弁膜症 #AS 予想通り！ 今後は70代の患者さんは、tav in tavが出来る解剖ならば優れた外科医がいて、上手なtaviが提供出来る施設で、tavi 1stで良いですね！ Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/EOfDZUvxLb
RT @ZHeart11768530: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
RT @VijayKunadian: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM #TCT2023 https://t.co/TWDLpGlOOW
RT @HiroyukiOkura: さきほどTCTで発表されました。Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/1bbX8Nu68D
RT @davidcalle1390: ❤️
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/HJKuJjPNF2
RT @VijayKunadian: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM #TCT2023 https://t.co/TWDLpGlOOW
さきほどTCTで発表されました。Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM https://t.co/1bbX8Nu68D
❤️
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years | NEJM #TCT2023 https://t.co/TWDLpGlOOW
N
DF
PP
PK
MB
D
M
CM
EC
UM
EP
DK
JC
MS
BE
DW
B
BA
LC
A
JS
KG
CF
DM
東循
يا
Dا
猫
が
吉
と
IM
PF
SS
NA
JH
PB
EA
دس
Dم
JK
GB
MG
DT
DG
SC
DH
JM
SC
CN
ف
GF
AB
CF
CM
CD
DT
DA
JM
DE
LD
?
RS
M
通
MM
KF
I
DO
GM
DW
JA
GF
N
CD
P
BZ
Aا
T
SK
MA
CM
AM
OB
DG
VM
JA
ワ
EC
DS
A
EV
S
AM
MS
B
MC
MI
CR
AV
AA
C
EA
BM
D
EP
E
MD
TM
MP
LT
JV
C
SA
ER
MM
MH
RR
TF
AM
GB
JC
HH
CF
M
S智
AR
SA
PS
CM
FR
BS
G
AC
MO
TF
AF
VD
KM
SA
TH
D
M
A
MP
SB
H大
DC